We found that a drug approved and indicated for aging would conservatively have a peak global market size ~$150-$200 billion annually.
A company that owned only this drug would be more valuable than the top 2 big pharma companies (J&J and Pfizer) in terms of revenue…combined.
20 years ago, scientists figured out how to make mice live 150% longer by altering one singular gene. What have we learned since this groundbreaking discovery?
In our debut video,
@alexkesin
seeks to find out.
Confirmed:
@loyalfordogs
just got a shoutout at the Emmys! Before our very eyes, we're starting to see public acceptance of aging drugs.
@celinehalioua
is truly a phenom. We are proud and thrilled of what she and Loyal are accomplishing every day.
As we ring in the new year, the age1 team has put together a New Year’s Company Wish List of ideas we’d love to see future founders work on.
We want exceptional founders to work on achieving healthy lifespan extension in the next decade.
An aging drug is a drug that has been rigorously shown to increase healthy lifespan in people, with emphasis on the ability of such an intervention to extend quality of life. It could allow older adults to enjoy a higher quality of life, for longer.
We're proud to share our ambitious plan to get an aging drug on pharmacy shelves within a decade.
Introducing the Longevity Funnel Framework (LFF), spearheaded by our very own
@maggie_1i
.
Happy Lunar New Year! To celebrate, we’re giving away some books that we love
Like + repost for a chance to be one of 5 lucky people to win a brand new book, endorsed by the age1 team!
More on the exciting implications of this study from
@faunabio
via a
@NASA
grant!
Unraveling how mammals resist disease could lead to new aging interventions and enable long-term space travel
Congratulations to
@DocMarkerB
and
@Ryan
Sprenger for being awarded a
@NASA
Innovative Advanced Concepts (NIAC) grant to test the potential of hibernation to protect astronauts from the damaging effects of space travel!
Richard Miller is a renowned figure in our field.
We're delighted to soon share a new series focused on the latest developments in longevity biotech. We'll kick off with a special feature on the Interventions Testing Program, including insights from Dr. Miller himself.
In today's episode (Ep.
#281
) of The Drive, I speak with Rich Miller, M.D., Ph.D, the Director of the Center for Aging Research at the University of Michigan. We delve into potential life-extending interventions in mice and more.
Every disease resembling accelerated aging is linked to a mutation in genome maintenance - and yet there are only a handful of companies tackling this.
@alantomusiak
argues why genome instability is fundamental to aging, and why we must do more to address it.
What drives aging?
Entropy? Information loss? A software flaw? Mutations? Epigenetic drift?
Choose any - but it all comes down to maintaining the genome. And yet there are so few people working on this central pillar.
A post on why you should:
(1/7)
While women live longer on average, they experience a sharp decline in quality of life and health at menopause.
Why have we accepted this as an inevitable truth ?
Ground squirrels can lower their body temperatures to hibernate for weeks, before rewarming with their incredible ability to regulate metabolic activity.
They are 1 of the 65 hibernators (out of 450+ mammal species!) that
@faunabio
leverages for their Convergence AI platform.
It's with heavy hearts that we learn the news of Dr. Judy Campisi's passing.
She was a pioneer in understanding cellular senescence and the linkage between aging and cancer.
Very upsetting news for the longevity field. Dr. Judy Campisi, professor
@BuckInstitute
and co-founder of our portfolio company
@UnityBiotech
, has passed away.
Our giveaway is heating up...
Like + RT by 10pm PST tonight and you can be one of the lucky few to win a beautiful hardcover book, endorsed by yours (...ours?) truly :)
Happy Lunar New Year! To celebrate, we’re giving away some books that we love
Like + repost for a chance to be one of 5 lucky people to win a brand new book, endorsed by the age1 team!
We'll always remember her as a trailblazing scientist and a mentor who inspired so many.
Her dedication to exploring aging and disease has left an enduring mark through the countless lives she touched throughout her career. Rest in peace, Judy.
Our giveaway is heating up...
Like + RT by 10pm PST tonight and you can be one of the lucky few to win a beautiful hardcover book, endorsed by yours (...ours?) truly :)
1 - Loyal has earned what we believe is the FDA’s first-ever formal acceptance that a drug can be developed + approved for lifespan extension
2 - We have 'technical section complete' AKA the 'does it work' data for LOY-001 - our large dog lifespan extension drug - is done
Fauna is the first to identify novel targets by integrating data with human patients and animals that naturally resist disease.
Congrats to
@ashleyz413
@LindaBGoodman
and Katie +
@faunabio
team for $494 mil strategic collaboration with
@EliLillyandCo
!
Menopause is devastating – its onset is correlated with a dramatic increase in risk of multiple age related diseases, like osteoporosis, cancer, and diabetes.
In our latest post,
@_Carol_Mag
comprehensively covers the landscape of how to delay and treat menopause - a much needed primer for an overlooked condition that affects half the human population.
Why has menopause become a normal part of every woman's life, when it causes unnecessary suffering?
Why is reproductive aging research still significantly underfunded when half of the population experiences menopause?
I believe this *needs* to change, so I wrote a piece about
This profile of Judy from Science magazine, written 20 years ago, is worth sharing.
Predating her co-founding Unity Biotechnology by 5 years and her National Academy of Sciences induction by 14 years – it presciently predicts her future career successes.